title: Sequential or concurrent administration of trastuzumab in early breast cancer? Too early to judge.
authors.forename: Hatem A
authors.initials: HA
authors.lastname: Azim
authors.forename: Evandro
authors.initials: E
authors.lastname: de Azambuja
authors.forename: Marianne
authors.initials: M
authors.lastname: Paesmans
authors.forename: Martine J
authors.initials: MJ
authors.lastname: Piccart-Gebhart
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068878:Trastuzumab